In making its recommendations to all marketing authorisation holders of fluconazole containing products, the PRAC had considered the available evidence, including the review and assessment of the register-based cohort study “Association between use of oral fluconazole during pregnancy and risk of spontaneous abortion and stillbirth”, the cumulative review of all available data from clinical trials, post-marketing data and literature publications concerning the risk following exposure to fluconazole during pregnancy.